معرفی
David J. Baylink, MD is a Professor at Loma Linda University School of Medicine and School of Dentistry, holding multiple distinguished roles in Regenerative Medicine, Medicine, and Basic Sciences. As Head of the Regenerative Medicine Division, he has led groundbreaking research in bone metabolism and stem cell therapies.
- Doctor of Medicine, Loma Linda University (1957)
- Bachelor of Arts, Walla Walla University (1953)
Research Interests: His work spans bone biology, focusing on osteoporosis treatment, vitamin D applications in leukemia, and immune-modulating therapies. He has pioneered stem cell and gene therapy approaches for skeletal repair and developed novel strategies for AML treatment by targeting metabolic pathways.
Scientific Contributions: Recent publications highlight his team's discoveries in NFκB2 signaling, nutrient-gene therapies for AML, and vitamin D's role in intestinal stem cell regeneration. These studies appear in journals like Genome Biology and International Journal of Molecular Sciences.
Patents and Projects: Baylink holds multiple patents for engineered dendritic cells and bone growth compositions. He has received grants from NIH, DoD, and private pharmaceutical companies for clinical trials on osteoporosis and AML therapies.
